What is the appropriate management of ocular pruritus (eye itching)?

Management of Ocular Pruritus (Eye Itching)

Start with topical second-generation H1-antihistamines or dual-action antihistamine/mast-cell stabilizer agents as first-line therapy for ocular pruritus, which can be continued indefinitely without duration limits for symptom control. 1

First-Line Pharmacologic Management

• Initiate topical second-generation H1-antihistamines (such as bilastine 0.6%, which provides 16-hour relief with once-daily dosing) or dual-action agents that combine antihistamine with mast-cell stabilizing properties 1, 2
• These agents are significantly more effective than over-the-counter antihistamine/vasoconstrictor combinations and should be preferred 1
• Avoid chronic use of vasoconstrictor-containing drops because they cause rebound vasodilation after discontinuation, leading to worsening redness 3, 1
• Dual-action agents can be used for both acute and chronic allergic conjunctivitis without specified duration limits 1

Adjunctive Non-Pharmacologic Measures

• Apply cold compresses and refrigerated artificial tears to provide immediate symptomatic relief and dilute allergens and inflammatory mediators on the ocular surface 3, 1
• Counsel patients to avoid eye rubbing, as this behavior is linked to keratoconus development and corneal ectasia progression in allergic and atopic patients 1
• Implement allergen-avoidance strategies: wear sunglasses as a barrier, use hypoallergenic bedding, employ eyelid cleansers to remove allergens, wash clothes frequently, and shower before bedtime 3, 1

Management of Persistent or Recurrent Disease

• Add mast-cell stabilizer therapy for frequently recurrent or persistent symptoms that do not respond adequately to antihistamines alone 3, 1
• Newer combination agents with both antihistamine and mast-cell stabilizing properties are suitable for long-term use without duration restrictions 1
• If symptoms remain inadequately controlled, add a brief 1-2 week course of low-risk topical corticosteroids to the regimen 3, 1

Severe or Refractory Cases

• Topical cyclosporine 0.05% administered at least four times daily is effective for severe allergic conjunctivitis and prevents seasonal recurrences 1
• Topical cyclosporine 0.1% is FDA-approved specifically for vernal keratoconjunctivitis in both children and adults 1
• Topical tacrolimus may be considered for severe cases refractory to other treatments 3, 1
• These immunomodulators can be used long-term to reduce steroid dependence 1

Critical Monitoring Requirements

• Obtain baseline and periodic intraocular pressure measurements for any patient receiving corticosteroids beyond the brief 1-2 week acute course 1
• Perform periodic pupillary dilation to assess for cataract formation during corticosteroid therapy 1
• This monitoring is mandatory for any steroid use extending beyond short-term treatment 1

Important Caveats

• Avoid or use oral antihistamines cautiously because they can induce or worsen dry-eye syndrome and impair the tear film's protective barrier 3, 1
• If oral antihistamines are necessary, prescribe preservative-free artificial tears concomitantly to mitigate tear-film deficiency 3, 1
• Avoid indiscriminate use of topical corticosteroids as they can potentially prolong adenoviral infections and worsen herpes simplex virus infections 3
• Topical antihistamines provide faster and superior relief compared to systemic antihistamines and possess longer duration of action than vasoconstrictors, pure mast-cell stabilizers, NSAIDs, or corticosteroids 4

Differential Diagnosis Considerations

When ocular pruritus persists beyond 6 weeks despite appropriate treatment, consider alternative diagnoses including allergic contact dermatitis of the eyelids, atopic dermatitis, xerosis, dry eye syndrome, seborrheic dermatitis, blepharitis, rosacea, or neurogenic itch 5